Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 1991 Jun 18;69(9):379-86.
doi: 10.1007/BF01647409.

[Thrombocyte transfusion: clinical aspects, follow-up and complications]

[Article in German]
Affiliations
Review

[Thrombocyte transfusion: clinical aspects, follow-up and complications]

[Article in German]
D Söhngen et al. Klin Wochenschr. .

Abstract

Thrombocytopenia is the most common cause of bleeding tendency, and, if due to impaired platelet production, is best treated by platelet transfusions. Prophylactic transfusions for asymptomatic patients should be considered if platelet count is below 20,000/microliters. However, if bleeding occurs or surgery is inevitable, platelet count should be maintained above 50,000/microliters. The benefit of platelet transfusions has to be balanced against risks like fever, infections and haemolysis. The effectiveness of platelet transfusions should be examined after 1 and 24 hrs by measuring the corrected count increment (CCI). Not only alloimmunization is a reason for unsatisfactory platelet increments. A poor CCI can also be due to fever, sepsis, hepato-splenomegaly or special drugs, which must be taken into account when assessing the demand for platelet transfusions.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Alter HJ, Purcell RH, Holland PV, et al. Donor transaminase and recipient hepatitis. Impact on blood transfusion services. J Am Med Assoc. 1981;246:630–634. - PubMed
    1. Alter HJ, Purcell RH, Shih JW, et al. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. N Engl J Med. 1989;231:1494–1500. - PubMed
    1. Andrews AT, Zmijewski CM, Bowman HS, et al. Transfusion reaction with pulmonary infiltration associated with HLA specific leukocyte antibodies. Am J Clin Pathol. 1976;66:483–487. - PubMed
    1. Aster RH. Pooling of platelets in the spleen: role in the pathogeneses of “hypersplenic” thrombocytopenia. J Clin Invest. 1966;45:645–657. - PMC - PubMed
    1. Baldwin ML, Ness PM, Scott D, et al. Alloimmunization to D-antigen and HLA in D-negative immunosuppressed oncology patients. Transfusion. 1988;28:330–333. - PubMed

LinkOut - more resources